Publication date: 12 November 2026 Source: Blood, Volume 148, Issue 20 Author(s): Ferran Araujo-Ayala, Maria Ros, Raluca Alexandru, Judith Mateos-Jaimez, Alba Rodriguez-Garcia, Marta Giménez-Alejandre, María Villalba-Esparza, Pablo Mozas, Guillem Colell, Salut Colell, Mireia Bachiller, Ferran Nadeu, Andrea Rivero, Ariadna Giró, Daniel J. Hodson, Soumya Poddar, Armando López-Guillermo, Dolors Colomer, Alba Maiques-Diaz, José Ignacio Martín-Subero
CD70 overexpression at diagnosis predicts relapse and supports dual CD19-CD70 CAR T-cell therapy in follicular lymphoma. // Blood. – URL: https://www.sciencedirect.com/science/article/pii/S0006497126016952?dgcid=rss_sd_all
CD70 overexpression at diagnosis predicts relapse and supports dual CD19-CD70 CAR T-cell therapy in follicular lymphoma. Blood. https://www.sciencedirect.com/science/article/pii/S0006497126016952?dgcid=rss_sd_all
“CD70 overexpression at diagnosis predicts relapse and supports dual CD19-CD70 CAR T-cell therapy in follicular lymphoma.” Blood.
@article{article38022,
title = {CD70 overexpression at diagnosis predicts relapse and supports dual CD19-CD70 CAR T-cell therapy in follicular lymphoma},
journal = {Blood},
url = {https://www.sciencedirect.com/science/article/pii/S0006497126016952?dgcid=rss_sd_all}
}